Research Article Details

Article ID: A46953
PMID: 32749590
Source: Eur Radiol
Title: Coronary atherosclerosis profile in patients with end-stage liver disease prior to liver transplantation due to alcoholic fatty liver: a coronary CTA study.
Abstract: OBJECTIVES: To assess the coronary atherosclerosis profile by coronary computed tomography angiography (CTA) in patients with end-stage liver disease (ESLD) due to alcohol-related liver disease (ARLD) evaluated for liver transplantation (LT), in a retrospective matched case-controlled cohort study. METHODS: One hundred forty patients (age 60.6&#160;years&#8201;&#177;&#8201;9.8, 20.7% females) who underwent coronary CTA were included. Seventy patients with ESLD due to ARLD (ESLD-alc) were propensity score (1:1) matched for age, gender, and the major 5 cardiovascular risk factors with healthy controls. CTA analysis included the following: stenosis severity according to CAD-RADS as (0)&#8201;=&#8201;no, (1) minimal <&#8201;25%, (2) mild 25-50%, (3) moderate 50-70%, and (4) severe >&#8201;70% stenosis, total mixed plaque burden weighted for non-calcified component (G-score) and high-risk plaque criteria (Napkin-Ring, low attenuation plaque, spotty calcification, positive remodeling). RESULTS: Prevalence of coronary artery disease (CAD) was high (84.4%) in the ESLD-alc group but similar to controls. Stenosis severity was similar (CAD-RADS, 1.9 vs. 2.2, p&#8201;=&#8201;0.289). High-grade stenosis (>&#8201;70%) was observed in 12.5% of ESLD-alc patients. High-risk plaques were less frequent in the ESLD-alc cohort as compared to controls (4.5% vs. 37.5%, p&#8201;<&#8201;0.001), and total mixed plaque burden was lower (G-score, 4.9 versus 7.4, p&#8201;=&#8201;0.001). Plaque density was lower in controls (56.6HU&#8201;&#177;&#8201;3.2 vs. 91.3HU&#8201;&#177;&#8201;4.5, p&#8201;=&#8201;0.007) indicating more lipid-rich in controls, but higher mixed fibro-calcific plaque component in those with alcohol-related ESLD. CONCLUSION: Patients with alcohol-related ESLD exhibit more mixed fibro-calcified plaques but less plaque with high-risk features and less fibro-fatty plaque burden, while total CAD prevalence is high. KEY POINTS: &#8226; Patients with ESLD prior to LT have a high total prevalence of CAD and stenosis severity, which is similar to those of healthy controls with an identical cardiovascular risk profile. &#8226; Patients with ESLD prior to LT due to alcohol abuse have more calcific but less fibro-fatty plaque and less high-risk plaque. &#8226; CTA seems to be a useful imaging technique for risk stratification prior to LT.
DOI: 10.1007/s00330-020-07037-8